Medtronic | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Medtronic is a global leader in medical technology, services, and solutions, headquartered in Minneapolis, MN. The company focuses...
Medtronic is a global leader in medical technology, services, and solutions, headquartered in Minneapolis, MN. The company focuses on addressing significant health challenges through innovative products and services that improve the health and lives of millions worldwide. With a history of 75 years, Medtronic has pioneered numerous medical advancements, including the first battery-powered pacemaker and AI-enhanced cancer screening.
Website
Headquarters
Minneapolis, MN
Size
10,001+ employees
Industry
Medical Equipment Manufacturing
ποΈ Medtronic Product and Pricing News β
π Medtronic CEO, Management and Leadership Team β
βοΈ Medtronic Alternatives and Competitors β
πΌ Medtronic Hiring and Layoffs β
π€ Medtronic Developer, Integration and Automation News β
π Medtronic Financials, Fundraising and Valuation News β
ποΈ Medtronic Product and Pricing News
- Medtronic now uses the Monk Skin Tone Scale to create more inclusive AI and ensure clinical trials of medical devices are more inclusive.
- Medtronic received a CE mark for its next generation Endoflip 300 system, which measures pressure and dimensions in the esophagus and pylorus.
- On March 5, 2024, Medtronic launched a new disposable stapler for bariatric surgeries, showcasing ongoing innovation in surgical stapler technology.
- Medtronic has launched the next generation of Micra leadless pacemakers, Micra VR2 and Micra AV2, in Australia and New Zealand, offering extended longevity and remote monitoring.
- Medtronic has introduced the BISβ’ Advance monitoring system to enhance anesthetic effect monitoring and personalize dosing during total intravenous anesthesia.
- On November 7, 2024, Medtronic MiniMed secured a dismissal in a wrongful death case with the help of Greenberg Traurig LLP after a Rule 702 hearing.
- Medtronic's Evolut FX plus valves were implanted for the first time in Switzerland, marking a significant advancement for patients at risk for coronary events.
- Medtronic has adapted its pulse oximeter technology for more accurate readings on darker skin tones, as discussed at a recent dinner in Annapolis, MD.
π Medtronic CEO, Management and Leadership Team
-
SVP, Chief Technology and Innovation Officer, Medtronic and BOD Director, Gentherm[email protected]
-
Chief Medical Officer[email protected]
-
Chief V&V Test Engineer[email protected]
-
Director, Strategy & Chief of Staff[email protected]
-
Chief of Staff, Pelvic Health, Medtronic[email protected]
-
SVP & Chief Quality Officer[email protected]
-
Senior compliance officer
-
Chief Medical Officer, VP Clinical Research and Medical Science. Cardiac Ablation Solutions. Medtronic[email protected]
-
Regional Clinical Director & Chief Pharmaceutical Officer[email protected]
-
Vice President, US CRM Service and Service Transformation[email protected]
-
Vice President Surgical[email protected]
-
Vice President Finance[email protected]
-
President, Cardiac Surgery[email protected]
-
Vice President and General Manager, Medtronic Structural Heart[email protected]
-
CEO & Chairman Of The Board Of Directors[email protected]
-
CFO[email protected]
-
CFO, Neuroscience Portfolio[email protected]
-
CFO Medtronic NeuroVascular[email protected]
-
Vice President CFO Medtronic EurAsia
βοΈ Medtronic Alternatives and Competitors
- Boston Scientific |
- Sanofi |
- Olympus Corporation |
- Brainlab |
- B. Braun |
- Baxter International |
- BD |
- Johnson & Johnson |
- Intuitive Surgical |
- Edwards Lifesciences |
- Genentech |
- Hologic |
- GE Healthcare |
- Mindray |
- CONMED |
- Abbott Laboratories |
- Stryker Corporation |
- Siemens Healthineers
πΌ Medtronic Hiring and Layoffs
- Medtronic appointed Dr. Matthew Kroh as chief medical officer for Advanced and General Surgical Technologies.
- Gregorio Oliveira has joined Medtronic as CFO EMEA Region at Medtronic Diabetes in Spain, previously serving as Chief Financial Officer at Novartis EspaΓ±a.
- AndrΓ©s Cima has joined Medtronic as President Latam in Brazil, previously serving as CEO at Invested Companies / Portfolio Management & New Business Development at PΓ‘tria Investimentos.
- Josh Johnson has left Medtronic as the Americas Commercial Director in the United States, having previously held the same position at Medtronic.
- Kendra J. Grubb, MD, MHA, FACC has joined Medtronic as Vice President & Chief Medical Officer - Structural Heart in the United States, previously serving as Professor of Surgery & Medicine at Emory University.
- Medtronic is currently hiring for the position of Director of PMO and Labeling in the United States.
- Ivan Olea, MS has joined Medtronic as Senior Director Manufacturing in Greater Boston, previously holding a position at another company.
- Medtronic is currently hiring for the position of Principal IT Architect (Identity and Access Management Engineer) in Czechia.
π€ Medtronic Developer, Integration and Automation News
- On November 15, Medtronic signed a Memorandum of Understanding with Yashoda Group of Hospitals to become their Preferred Robotics Partner and integrate advanced robotic systems for surgery.
- Medtronic and Ping An Health have formed a strategic partnership to collaborate on cardiac health, chronic disease therapies, and medical clinical training.
- Medtronic has partnered with Becker's Healthcare to address health equity.
- Medtronic is collaborating with GI Alliance to implement the GI Geniusβ’ AI technology across 400 locations to enhance polyp detection during colonoscopies.
- Medtronic India has partnered with AIG Hospitals and the Indian School of Business to offer a course on artificial intelligence for healthcare professionals.
- Medtronic is partnering with Siemens Healthineers to integrate its AiBLE surgical suite with Siemens' Multitom Rax robotic X-ray scanner for robotic head and spine procedures, announced at the North American Spine Society meeting.
π Medtronic Financials, Fundraising and Valuation News
- Medtronic announced Q2 '25 results and raised its full-year guidance.
- Medtronic's first-quarter revenue reached $7.915 billion, with net income rising 32% to $1.04 billion and earnings per share increasing 36% to $0.80.
- Medtronic outperforms NeurAxis in revenue, earnings, and analyst ratings, with a consensus target price of $95.36 and strong institutional ownership of 82.1%.
People also viewed
- Cytovale |
- Hypervision Surgical |
- Big Cartel |
- FLYERALARM |
- Stan |
- Payhip |
- Gumroad |
- Podia